← brief for 2026-11-12 · Slowing decline
Endothelin Receptor Antagonists in CKD-Associated Resistant Hypertension: Trial Lessons, Safety Boundaries, and Conditions for Future Clinical Testing.
Key takeaways
This review discusses drugs for hard-to-control high blood pressure in kidney disease. It notes that these drugs can cause fluid retention. It also says we do not know if they protect the kidneys long term. There are no new trial results here.
Who did this work
Corrêa LMA · Brandão LKV · Delmiro Silva YR · Zanella J · Pinheiro IM
Source
Paper · PubMed, the drug frontier · 2026 Nov 12
https://pubmed.ncbi.nlm.nih.gov/43018899/